Antibiotic Prophylaxis With Routine Ureteral Stent Removal
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This study will be a single-institutional randomized, single-blinded prospectively controlled
clinical trial of a single dose of Ciprofloxicin 500mg antibiotic tablet as prophylaxis at
the time of office flexible cystoscopy with ureteral stent removal. The control group will be
no prophylaxis oral antibiotics.